Quay Pharma sponsors seminars in on medicines for children
The sponsorship highlights Quay’s involvement in paediatric medicine
UK-based pharmaceutical outsourcing specialist Quay Pharma is sponsoring and exhibiting at a series of UK-based seminar programmes in association with the NIHR Medicines for Children Research Network (MCRN) that will highlight the latest developments in the creation of medicines for children and adolescents.
The first event, Sharing Best Practice on Widening Participation in Children’s Research, took place in Manchester at the beginning of March. A second one day programme, the Trent Local Children's Research Network (TLC-RN) 4th Annual Paediatric Research Meeting, will be held in Nottingham on 4th May.
The keynote address at the Nottingham event will be from Professor Terence Stephenson, president of The Royal College of Paediatrics and Child Health, who will talk about A Decade of Change in Medicines for Children. In addition, professor Anne Greenhough, head of Kings College London School of Medicine and director of Education and Training at Kings Health Partners, will be presenting the national picture of Non-Medicines Paediatric Research, while there will also be a series of presentations and case studies on MCRN and non-medicines paediatric research.
Quay’s involvement in these events is part of the company’s ongoing development of medicines that specifically target prevention, diagnosis and treatment in young people.
‘It is becoming increasingly clear that reduced doses of proven adult drugs may not always be the most effective way to treat children and adolescents,’ said Mike Rubinstein, ceo of Flintshire-based Quay Pharma.
‘There is a lot of important work currently taking place in paediatric drug research and development and we are delighted to be able to highlight this through our support for these events. This type of work is also an important part of our own operations and is another area of expertise that we can offer to our client base.’
